Development of CDK5-P25 modulator to treat alzheimer's disease and frontotemporal dementia
Ended Project Grant Awarded Last action
- Award ID
- R43AG062058
- Recipient
-
Cogentis Therapeutics Inc. UEI T5K6EP6DD251
- Awarding agency
-
National Institute on Aging
National Institutes of Health, Department of Health and Human Services
- Obligated
- $732,659
Award facts
- Assistance listing
- 93.866 Aging Research
- Completion date
- Originally
- Place of performance
- Maryland, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$393 | |
| Amendment | -$393 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $236,325 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $497,121 |
Show all 14
Quick answers
Who received award R43AG062058?
R43AG062058 was awarded to Cogentis Therapeutics Inc. by National Institute on Aging (National Institutes of Health) on September 30, 2018.
How much is award R43AG062058 worth?
$732,659 has been obligated on R43AG062058.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award